Sil, Moumita; Goswami, Anamitra; Mukherjee, Dipro; Mukherjee, Nabanita; Polikarpov, Igor 
; Goswami, Arunava; Nag, Moupriya; Lahiri, Dibyajit
Source: Nanomedicine: Nanotechnology, Biology, and Medicine. Unidade: IFSC
Subjects: PLANEJAMENTO DE FÁRMACOS, NANOCIÊNCIA, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIL, Moumita et al. Withaferin A and Withanolide A-mediated silver nanoparticles target bacterial motility, metabolism, and stress adaptation in E. coli. Nanomedicine: Nanotechnology, Biology, and Medicine, v. 68, p. 102846-1-102846-13, 2025Tradução . . Disponível em: https://doi.org/10.1016/j.nano.2025.102846. Acesso em: 29 jan. 2026.APA
Sil, M., Goswami, A., Mukherjee, D., Mukherjee, N., Polikarpov, I., Goswami, A., et al. (2025). Withaferin A and Withanolide A-mediated silver nanoparticles target bacterial motility, metabolism, and stress adaptation in E. coli. Nanomedicine: Nanotechnology, Biology, and Medicine, 68, 102846-1-102846-13. doi:10.1016/j.nano.2025.102846NLM
Sil M, Goswami A, Mukherjee D, Mukherjee N, Polikarpov I, Goswami A, Nag M, Lahiri D. Withaferin A and Withanolide A-mediated silver nanoparticles target bacterial motility, metabolism, and stress adaptation in E. coli [Internet]. Nanomedicine: Nanotechnology, Biology, and Medicine. 2025 ; 68 102846-1-102846-13.[citado 2026 jan. 29 ] Available from: https://doi.org/10.1016/j.nano.2025.102846Vancouver
Sil M, Goswami A, Mukherjee D, Mukherjee N, Polikarpov I, Goswami A, Nag M, Lahiri D. Withaferin A and Withanolide A-mediated silver nanoparticles target bacterial motility, metabolism, and stress adaptation in E. coli [Internet]. Nanomedicine: Nanotechnology, Biology, and Medicine. 2025 ; 68 102846-1-102846-13.[citado 2026 jan. 29 ] Available from: https://doi.org/10.1016/j.nano.2025.102846
